By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
Indoco Company Profile
Email this page to a colleague
What is the competitive landscape for INDOCO, and what generic and branded alternatives to INDOCO drugs are available?
INDOCO has ten approved drugs.
There is one tentative approval on INDOCO drugs.
Summary for Indoco
| US Patents: | 0 |
| Tradenames: | 10 |
| Ingredients: | 10 |
| NDAs: | 10 |
Drugs and US Patents for Indoco
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indoco | ALLOPURINOL | allopurinol | TABLET;ORAL | 204467-002 | Jul 28, 2016 | AB | RX | No | No | Get Started Free | Get Started Free | ||||
| Indoco | RASAGILINE MESYLATE | rasagiline mesylate | TABLET;ORAL | 206153-001 | Oct 4, 2019 | AB | RX | No | No | Get Started Free | Get Started Free | ||||
| Indoco | OLANZAPINE | olanzapine | TABLET;ORAL | 206155-003 | Jul 31, 2020 | AB | RX | No | No | Get Started Free | Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
